These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 10605190)

  • 1. [Preventing HIV infection: an exercise in evaluating scientific evidence in public health].
    Guerra-Romero L; Noguer I; Bolea A; Suárez M; Parras F
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():67-75. PubMed ID: 10605190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reduction of mother-child transmission of HIV infection in Africa: from clinical research to public health programs].
    Leroy V; Dabis F
    Med Trop (Mars); 1999; 59(4 Pt 2):456-64. PubMed ID: 10901847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventing the transmission of HIV-1 from mother to child in Africa in the year 2000].
    Castetbon K; Leroy V; Spira R; Dabis F
    Sante; 2000; 10(2):103-13. PubMed ID: 10960807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the HIV/AIDS epidemic, scientific research and government responses in China.
    Wang L
    AIDS; 2007 Dec; 21 Suppl 8():S3-7. PubMed ID: 18172388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of mother-to-child transmission of HIV--successes, controversies and critical questions.
    Abrams EJ
    AIDS Rev; 2004; 6(3):131-43. PubMed ID: 15595430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prevention research in HIV vaccine trials.
    Vermund SH
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S303-5. PubMed ID: 7865326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
    Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
    AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based HIV behavioral prevention from the perspective of the CDC's HIV/AIDS Prevention Research Synthesis Team.
    Lyles CM; Crepaz N; Herbst JH; Kay LS;
    AIDS Educ Prev; 2006 Aug; 18(4 Suppl A):21-31. PubMed ID: 16987086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV prevention and psychoactive drug use: a research agenda.
    Des Jarlais DC; Semaan S
    J Epidemiol Community Health; 2009 Mar; 63(3):191-6. PubMed ID: 19218258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.
    Wodak A; Cooney A
    Subst Use Misuse; 2006; 41(6-7):777-813. PubMed ID: 16809167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of HIV prevention interventions in developing countries.
    Merson MH; Dayton JM; O'Reilly K
    AIDS; 2000 Sep; 14 Suppl 2():S68-84. PubMed ID: 11061644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials.
    Crepaz N; Lyles CM; Wolitski RJ; Passin WF; Rama SM; Herbst JH; Purcell DW; Malow RM; Stall R;
    AIDS; 2006 Jan; 20(2):143-57. PubMed ID: 16511407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring effectiveness in community randomized trials of HIV prevention.
    Hallett TB; Garnett GP; Mupamberiyi Z; Gregson S
    Int J Epidemiol; 2008 Feb; 37(1):77-87. PubMed ID: 18096590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in mother-to-child transmission of HIV in Thailand, 2001-2003: Results from population-based surveillance in six provinces.
    Plipat T; Naiwatanakul T; Rattanasuporn N; Sangwanloy O; Amornwichet P; Teeraratkul A; Ungchusak K; Mock P; Levine W; McConnell MS; Simonds R; Culnane M
    AIDS; 2007 Jan; 21(2):145-51. PubMed ID: 17197804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M;
    Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions to prevent HIV risk behaviors. National Institutes of Health Consensus Development Conference Statement February 11-13, 1997.
    AIDS; 2000 Sep; 14 Suppl 2():S85-96. PubMed ID: 11061645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.